Mallinckrodt and Welch Allyn extend agreement:
This article was originally published in Clinica
Executive Summary
Mallinckrodt has extended its technology integration agreement with Welch Allyn for a further three years. Under the deal, originally formed in April 1997, Welch Allyn can incorporate Mallinckrodt's Nellcor oximetry technology into its patient monitoring devices. The technology is used in two of Skaneateles Falls, New York-based Welch Allyn's ranges, the Atlas multi-parameter monitor and the Vital Signs monitor.